Multi-Jurisdictional CAC Meeting Announcement - Biomarkers Utilized in the Diagnosis of Synucleinopathies - August 20, 2026, 2-4pm CT

Date Posted: July 9, 2026

This article has been published for notice under contract numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).

Palmetto GBA, Wellpoint Administrators, and Noridian Healthcare Solutions will host a Multi-Jurisdictional Contractor Advisory Committee (CAC) Meeting via Microsoft Teams on August 20, 2026, from 2-4pm CT. Discussions will focus on Biomarkers Utilized in the Diagnosis of Synucleinopathies.

The Centers for Medicare & Medicaid Services (CMS) assigned Medicare Administrative Contractors (MACs) the task of developing Local Coverage Determinations (LCDs). The purpose of the CAC meeting is to provide a formal mechanism for healthcare professionals to be informed of the evidence used in developing an LCD and promote communications between the MACs and the healthcare community. The CAC panel will discuss the clinical literature related to Biomarkers Utilized in the Diagnosis of Synucleinopathies. Discussions will occur between CAC panelists and Contractor Medical Directors. The public may attend; however, questions from the public will not be entertained.

Interested stakeholders are invited to attend via Microsoft Teams; however, advanced registration is required.

Note: Registration deadline to participate by listen-only mode will close on August 20, 2026. Once registered you will receive the Microsoft Teams information via email. Lines will remain muted throughout the conference except for the invited CAC panelists and the MAC hosts.

View meeting details and register now from the CAC Meeting webpage.

Last Updated Jul 09 , 2026